Optimizing postoperative chemotherapy for ampullary cancer: A risk-driven approach to precision care

Not all patients benefit from POCT. The proposed nomogram predicts survival effectively and can guide treatment decisions, optimizing outcomes by providing additional chemotherapy for high-risk patients while sparing low-risk patients from unnecessary treatment.

Authors

Institutions

Publication Details

Journal
iLiver
Published
2025-04-26
DOI
https://doi.org/10.1016/j.iliver.2025.100166
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimizing postoperative chemotherapy for ampullary cancer: A risk-driven approach to precision care

Mingru Liu, Yuan Zheng, Jiaoyang Lu, Di Zhang
iLiver
Pancreatic and Hepatic Oncology Research
article

Optimizing postoperative chemotherapy for ampullary cancer: A risk-driven approach to precision care

Mingru Liu, Yuan Zheng, Jiaoyang Lu, Di Zhang
article en

Abstract

Not all patients benefit from POCT. The proposed nomogram predicts survival effectively and can guide treatment decisions, optimizing outcomes by providing additional chemotherapy for high-risk patients while sparing low-risk patients from unnecessary treatment.

iLiverVol. 4(2)
Shandong University (CN), Qilu Hospital of Shandong University (CN)
Good health and well-being
Openalex Percentile: Top 87%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.